Daniel F. Argolo

Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study

Lillian M. Smyth, Neil M. Iyengar, M. F. Chen et al. · Breast Cancer Research and Treatment · 2016 · 38 citations · Full text

Medicine, Oncology, Pharmacology +17

Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience

Jasmeet Singh, Anita Mamtani, Andrea V. Barrio et al. · The Oncologist · 2017 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17

Obesity and Cancer: Concepts and Challenges

Daniel F. Argolo, Neil M. Iyengar, Clifford A. Hudis · Indian Journal of Surgical Oncology · 2015 · 16 citations · Full text

Medicine, Nutrition, Oncology +10

Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study

Leandro Jonata de Carvalho Oliveira, Thais Baccili Cury Megid, Daniela Dornelles Rosa et al. · Therapeutic Advances in Medical Oncology · 2022 · 10 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17